Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United Kingdom”

A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)Terminated
NCT05665595Phase 3Updated Sep 10, 2026
Sponsor: Merck Sharp & Dohme LLC
Melanoma
United States, Argentina, Australia, Austria, Belgium +21 more
Controlled Oxygen Desaturation Study of the Neonatal Wireless Transmission SystemNot Yet Recruiting
NCT07813091EARLY_Phase 1Updated Sep 10, 2026
Sponsor: Kathryn Beardsall
Testing Accuracy · Device Performance
United Kingdom
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With PsoriasisCompleted
NCT04036435Phase 3Updated Sep 10, 2026
Sponsor: Bristol-Myers Squibb
Psoriasis
United States, Australia, Canada, China, Czechia +15 more
Digital App for Speech & Health MonitoringRecruiting
NCT06450418N/AUpdated Sep 10, 2026
Sponsor: University of Edinburgh
Dementia · Motor Neuron Disease · Multiple Sclerosis · Parkinson Disease
United Kingdom
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene TherapyRecruiting
NCT05861999Phase 4Updated Sep 10, 2026
Sponsor: Hoffmann-La Roche
Muscular Atrophy, Spinal
United States, Germany, Israel, Poland, Qatar +1 more
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)Active Not Recruiting
NCT04624204Phase 3Updated Sep 10, 2026
Sponsor: Merck Sharp & Dohme LLC
Small Cell Lung Cancer
United States, Australia, Belgium, Bulgaria, Canada +20 more
STOP-HAE: A Phase 3 Study of ADX-324 in HAERecruiting
NCT06960213Phase 3Updated Sep 10, 2026
Sponsor: ADARx Pharmaceuticals, Inc.
Hereditary Angioedema · HAE · Hereditary Angioedema - Type 1 · Hereditary Angioedema - Type 2
United States, Argentina, Australia, Austria, Belgium +19 more
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusRecruiting
NCT07776509Phase 3Updated Sep 10, 2026
Sponsor: AstraZeneca
Obesity or Overweight · Weight-Related Comorbidity · With/Without Diabetes Mellitus, Type 2
United States, Argentina, Brazil, Canada, China +6 more
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsRecruiting
NCT06008197Phase 3Updated Sep 10, 2026
Sponsor: Colorado Prevention Center
Heart Failure · Acute Heart Failure
United States, Argentina, Australia, Brazil, Bulgaria +21 more
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationTerminated
NCT05636176Phase 3Updated Sep 10, 2026
Sponsor: Novo Nordisk A/S
Heart Failure
United States, Argentina, Australia, Austria, Belgium +41 more
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLCRecruiting
NCT06303505Phase 1, Phase 2Updated Sep 9, 2026
Sponsor: Tubulis GmbH
Ovarian Cancer · Non-small Cell Lung Cancer
United States, Belgium, Germany, Romania, Spain +2 more
A Study to Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic CoughRecruiting
NCT07690059Phase 2Updated Sep 9, 2026
Sponsor: Sensory Cloud, Inc.
Refractory Chronic Cough and Unexplained Chronic Cough
United Kingdom
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMRecruiting
NCT07667803Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Weight Management
United States, Argentina, Australia, Brazil, Canada +14 more
Advanced Diffusion Magnetic reSonance Prostate Imaging for Reducing Extraneous Biopsies (ASPIRE) - Calibration Component (Multi-centre Scanner Calibration) and Validation Component (Multi-centre Validation)Not Yet Recruiting
NCT07808528NAUpdated Sep 9, 2026
Sponsor: University College, London
Prostate Cancer (Diagnosis)
United Kingdom
A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related ComorbidityActive Not Recruiting
NCT06965413Phase 2Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Obesity · Overweight · Overweight With One Weight Related Comorbidity
United States, Poland, Spain, United Kingdom
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)Active Not Recruiting
NCT05371613Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: Denali Therapeutics Inc.
Mucopolysaccharidosis II
United States, Argentina, Belgium, Brazil, Canada +9 more
The Effectiveness of Early Intervention to Correct the Position of PDC:sRecruiting
NCT06267989NAUpdated Sep 9, 2026
Sponsor: Göteborg University
Ectopic Tooth Eruption · Palatal Expansion Technique · Randomized Clinical Trial
Germany, Sweden, United Kingdom
Optical Coherence Tomography in Acute Vessel EvaluationEnrolling By Invitation
NCT07422688NAUpdated Sep 9, 2026
Sponsor: Aarhus University Hospital Skejby
Ischemic Heart Disease · Ischemic Coronary Artery Disease · ACS (Acute Coronary Syndrome)
Belgium, Denmark, Estonia, Finland, Italy +7 more
Influence of Gut Microbiome in Gallstone DiseaseRecruiting
NCT05732480N/AUpdated Sep 9, 2026
Sponsor: East Kent Hospitals University NHS Foundation Trust
Gall Stone · Gall Stones, Common Bile Duct · Pancreatitis · Acute Cholecystitis
United Kingdom
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck CancerActive Not Recruiting
NCT04590963Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Squamous Cell Carcinoma of the Head and Neck
United States, Argentina, Australia, Austria, Belgium +18 more
A Study of Eptinezumab in Pediatric Participants With Episodic MigraineRecruiting
NCT05897320Phase 3Updated Sep 9, 2026
Sponsor: H. Lundbeck A/S
Episodic Migraine
United States, Argentina, Canada, Italy, Mexico +6 more
Development and Psychometric Validation of the Medical Dismissal ScaleActive Not Recruiting
NCT07809373N/AUpdated Sep 9, 2026
Sponsor: King's College London
Any Condition
United Kingdom
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple MyelomaRecruiting
NCT06980480Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Multiple Myeloma · Secondary Immunodeficiency
United States, Australia, Austria, Brazil, Canada +11 more
Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney DiseaseActive Not Recruiting
NCT06747572N/AUpdated Sep 9, 2026
Sponsor: Vertex Pharmaceuticals Incorporated
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
United States, Belgium, Canada, France, Germany +4 more
FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALSRecruiting
NCT07674667Phase 1, Phase 2Updated Sep 9, 2026
Sponsor: Trace Neuroscience, Inc.
Amyotrophic Lateral Sclerosis
Germany, Netherlands, United Kingdom

Previous page Next page